As per MRFR analysis, the India Biomaterial Market Size was estimated at 2.62 (USD Billion) in 2023.The India Biomaterial Market Industry is expected to grow from 3.5(USD Billion) in 2024 to 7.2 (USD Billion) by 2035. The India Biomaterial Market CAGR (growth rate) is expected to be around 6.777% during the forecast period (2025 - 2035).
The India biomaterial market is expanding quickly for a variety of reasons. One of the most important factors is the rising need for sustainable and eco-friendly materials aligned with biomaterials requisites plastic waste reduction and environmental sustainability.
Programs like the Swachh Bharat Mission catalyze the need for biodegradable materials, paving the way for biomaterials usage in several industries. Additionally, the swift expansion of the healthcare and medical sectors drives the biomaterials industry forward due to increased mergence on healing wounds, tissue engineering, implants, and other services that are more compatible with living tissues and systems.
The biomaterials industry in India is full of untapped potential. Start-ups and small scale industries engaged in biomaterials are receiving support from the government through innovation schemes. There’s an opportunity for local firms to invest in advanced research and development aimed at the medical sector, especially with custom surgical packing, as well as in the packaging industry. In addition, the growth of the bio-based products industry provides some new and unexplored opportunities for investment that capitalize on the shift in consumer sentiment towards greener products. Over the past year or so, there seems to be an amplified focus among consumers and businesses on health, safety, and sustainability.
An observable increase in partnerships and collaborations between industries, academia, and government agencies is evident as the market value of biomaterials increases. To achieve the desired innovations and maintain competitiveness in the biomaterial space, this collaboration is important. Along with supporting policies, the increasing consumer awareness towards worsening sustainable practices is a contributing factor to the growing biomaterial market in India.
[Image of India Biomaterial Market Growth Chart]
The rising healthcare expenditure in India is a significant driver for the India Biomaterial Market Industry. According to the National Health Accounts, India's healthcare spending is expected to rise from USD 72 billion in 2020 to USD 157 billion by 2025. This increase in spending allows for the adoption of advanced medical technologies, including biomaterials, which are crucial for tissue engineering, implants, and drug delivery systems.
Companies such as Tata Consultancy Services and Wockhardt Limited have been investing heavily in Research and Development for biomaterials, contributing to market growth. Moreover, the push for better healthcare infrastructure by the Indian government, aiming to achieve Universal Health Coverage by 2025, is anticipated to lead to a higher demand for innovative biomaterials, thus, significantly impacting the growth trajectory of the India Biomaterial Market.
The increasing incidence of chronic diseases, such as diabetes and cardiovascular diseases, is driving the India Biomaterial Market Industry. According to the Indian Council of Medical Research, the prevalence of diabetes is estimated to reach 134 million by 2045. This rise in chronic illnesses leads to a growing demand for biomaterials used in surgical and therapeutic applications.
For instance, companies like Meril Life Sciences and Biocon have been developing advanced biomaterials designed for chronic disease management. The requirement for biocompatible materials for implants and prosthetics ensures a vital role for biomaterials in the medical field, thereby boosting the market's growth.
The Indian government's initiatives to promote the development and adoption of biomaterials are essential drivers for the India Biomaterial Market Industry. Policies such as the 'Make in India' initiative and the National Biopharma Mission foster innovation in the healthcare sector. The Biotechnology Industry Research Assistance Council (BIRAC) has launched several funding programs aimed at promoting research in biomaterials and providing support to startups in this field.
This government backing not only incentivizes local production but also encourages collaborations between educational institutions and manufacturers. With increased funding, more companies are likely to engage in Research and Development for innovative biomaterials, thus propelling the market's growth.
The Application segment of the India Biomaterial Market entails several crucial areas that are significantly impacting the healthcare landscape in the country. Increasing healthcare expenditure in India has led to a growing focus on innovative medical solutions using biomaterials, which include essential applications like Medical Devices, Tissue Engineering, Drug Delivery, Orthopedics, and Wound Care. The Medical Devices segment is pivotal, accounting for a substantial market share, as advancements in technology are leading to the development of more efficient and safer devices.
Tissue Engineering has garnered significant attention for its potential in regenerative medicine, allowing for the repair and replacement of damaged tissues, crucial for an aging population and increasing incidences of chronic diseases. Drug Delivery systems utilizing biomaterials are enhancing the effectiveness of therapeutic interventions, ensuring that medications are delivered locally and efficiently, which is critical for personalized medicine approaches in India. The Orthopedics application is vital in addressing the preventive and corrective treatment of musculoskeletal disorders, underlining the importance of innovative biomaterials that provide better functional outcomes for patients.
Wound Care is emerging as a significant application due to the increasing prevalence of diabetic ulcers and burn injuries, necessitating advanced biomaterials that promote faster healing and reduce the risk of infections. Overall, the India Biomaterial Market segmentation indicates a notable trend toward using these advanced materials across various applications, which promises enhanced patient care and a significant shift in healthcare practices across the country. As India continues to expand its healthcare infrastructure, the opportunities for growth in these applications are considerable, driven by ongoing Research and Development efforts, rising demand for biocompatible materials, and the need for customized healthcare solutions.
Emerging trends indicate a focus on sustainable and biodegradable biomaterials which align with global sustainability goals, offering promising avenues for businesses and investors in the biomaterial landscape in India.
[Image of India Biomaterial Market Application Share]
The India Biomaterial Market is diversely segmented into Natural Biomaterials, Synthetic Biomaterials, and Modified Biomaterials, reflecting the varied applications and unique properties of each category. Natural Biomaterials, sourced from plants and animals, are increasingly preferred for their biocompatibility and eco-friendliness, making them significant in areas like tissue engineering and regenerative medicine. Conversely, Synthetic Biomaterials offer versatility and tailored properties, leading to widespread use in medical devices and implants, highlighting their importance in advancing healthcare technology.
Modified Biomaterials, which are engineered to enhance performance characteristics, are gaining traction in drug delivery systems and biosensors, showcasing their pivotal role in driving innovations in the medical field. The increasing demand for sustainable solutions and advancements in biomedical applications continue to boost the growth and significance of these segments within the India Biomaterial Market, further emphasizing the critical interplay between technological development and market needs. Additionally, the government's focus on promoting research and development in this sector adds to the growth potential, as India aims to become a hub for biomaterials in the global marketplace.
The India Biomaterial Market is witnessing significant growth driven by the increasing demand for sustainable and eco-friendly materials across various industries. Among the different sources of biomaterials, plant-based materials take the forefront due to their renewability, accessibility, and versatility in multiple applications, making them a key player in packaging and construction sectors. Animal-based biomaterials also remain relevant, particularly in the medical field, as they offer unique properties for developing tissues and other medical products.
Microbial-based biomaterials are emerging as innovative solutions in waste management and biocompatible materials, showing a promising growth trajectory. These diverse sources highlight the importance of the India Biomaterial Market segmentation, allowing manufacturers to cater to specific needs while fostering innovation and sustainability. Furthermore, the government's push for green technology and the growing awareness around the environmental impact of traditional materials contribute to the opportunities within this market. The dynamic interplay between these sources not only signifies their individual importance but also solidifies India's position as a rising hub for biomaterial development.
The End Use segment of the India Biomaterial Market plays a crucial role in shaping the overall market dynamics, particularly with respect to the Healthcare, Pharmaceuticals, and Cosmetics sectors. The Healthcare sector notably stands out due to the increasing demand for biocompatible materials used in medical implants and devices, reflecting growing advancements in medical technology. In Pharmaceuticals, biomaterials are essential for drug delivery systems, providing significant improvements in therapeutic effectiveness and patient compliance.
The Cosmetics industry increasingly leverages biomaterials to create sustainable and skin-friendly products, driven by rising consumer awareness about the environmental impacts of synthetic ingredients. As the Indian government emphasizes the need for innovation in healthcare and sustainability, the demand for biomaterials is becoming integral across these industries. Factors such as advancements in Research and Development, along with expanding applications in tissue engineering and regenerative medicine, further underline the growth potential within the India Biomaterial Market. The ongoing focus on sustainability and eco-friendliness aligns with global trends, making the End Use segment vital for the future landscape of biomaterials in India.
The India Biomaterial Market is witnessing substantial growth driven by increasing awareness about environmental sustainability and the need for eco-friendly alternatives to traditional materials. As the market expands, competition intensifies with numerous players innovating and offering diverse products to meet the rising demand for biomaterials across various applications. Factors such as government initiatives promoting green technology, advancements in material science, and the growing adoption of biodegradable materials in packaging, healthcare, and consumer goods contribute significantly to the competitive landscape. The country's commitment to reducing plastic waste and transitioning to sustainable materials presents lucrative opportunities for companies specializing in biomaterial solutions, intensifying their focus on R&D and strategic partnerships to capture market share and address consumer needs.
Novamont emerges as a significant player within the India Biomaterial Market, effectively leveraging its strengths to establish a notable presence. The company's commitment to incorporating innovation in the development of biodegradable and compostable materials has resonated well in the Indian market, aligning with the growing demand for sustainable products. Novamont's diverse range of offerings, including bioplastics used in packaging and agricultural applications, underscores its adaptability to varying market demands. The company's strategic collaborations with local manufacturers and distributors further enhance its market penetration, ensuring that its products reach a broader consumer base across India. Novamont's ongoing focus on sustainability and performance distinguishes it in a competitive environment, allowing it to cater to both consumer preferences and regulatory requirements.
Evonik Industries stands out as a prominent contender in the India Biomaterial Market, offering an extensive portfolio of innovative solutions tailored to local demands. The company specializes in high-performance biomaterials that serve a diverse range of industries, including healthcare, automotive, and consumer goods. Evonik’s focus on researching and developing sustainable materials positions it as a leader in providing high-quality, environmentally friendly alternatives. The presence of specialized products like biodegradable polymers is complemented by the company's commitment to local partnerships and collaborations that enhance its reach within India. Moreover, Evonik Industries' strategic mergers and acquisitions have bolstered its operational capacity, allowing for efficient production and delivery of biomaterials. This proactive approach enables Evonik to leverage upcoming market trends effectively, establishing a competitive edge while contributing to a more sustainable future in India.
The India Biomaterial Market has seen significant developments recently. In June 2023, Novamont announced the launch of new biodegradable materials aimed at reducing plastic waste, aligning with India's focus on sustainable practices. Additionally, Evonik Industries collaborated with local players to enhance their production capabilities for biopolymers, fostering innovation in the sector. Both Corbion and Total Corbion PLA have expanded their footprint in India, reflecting the growing demand for bioplastics in packaging applications.
Notably, in March 2023, Mitsubishi Chemical completed its acquisition of BioAmber's assets, marking a strategic move to enhance their biobased portfolio in the region. NatureWorks has also been investing in Research and Development to scale up Ingeo production within India. As of 2023, Bain Capital has shown interest in the Indian market, diversifying investments towards sustainable materials, signaling positive growth prospects. The valuation of companies like BASF and DuPont in the biopolymer space has increased following these developments, significantly impacting market dynamics. The Indian government’s push for greener technologies and initiatives like the Plastic Waste Management Rules are also contributing to the burgeoning growth of the biomaterial market.
| Report Attribute/Metric | Details |
| Market Size 2023 | 2.62 (USD Billion) |
| Market Size 2024 | 3.5 (USD Billion) |
| Market Size 2035 | 7.2 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.777% (2025 - 2035) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Novamont, Evonik Industries, Corbion, Willow Technologies, Green Dot Bioplastics, BASF, NatureWorks, Bain Capital, Mitsubishi Chemical, BioAmber, Total Corbion PLA, Sierra Renewables, Genomatica, DuPont, Archroma |
| Segments Covered | Application, Type, Source, End Use |
| Key Market Opportunities | Rising demand for sustainable materials, Growing healthcare infrastructure investments, Increasing applications in packaging, Government incentives for biopolymer development, Expanding research in tissue engineering |
| Key Market Dynamics | increasing healthcare spending, government support initiatives, rising bioplastics demand, sustainability concerns, growing research activities |
| Countries Covered | India |
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
